Can an MRI scan replace a prostate biopsy? Discover how 2026 EAU guidelines use multiparametric MRI to prevent unnecessary ...

DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE)-- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced ...

To evaluate changes in PI-RADS ≥ 3 lesions on prostate MRI after prostate artery embolization (PAE) performed for lower urinary tract symptoms. This retrospective single-center study included 18 ...

Thank you for joining us today. I'm Robert Burns, the Managing Director and Senior Biotech Analyst at H.C. Wainwright. I'm joined today by Chris Behrenbruch, the CEO of Telix; and David Cade, the CMO ...

PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...

Dr. Aytekin Oto discussed Prostate MRI 101, noting that prostate MRI has evolved significantly since its first publication in 1982, with multiparametric MRI now embraced worldwide. With regards to ...

In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...

Objective: To evaluate the diagnostic value of prostate-specific antigen (PSA) density, digital rectal examination (DRE), and family history in predicting prostate cancer among patients with low-risk ...

An artificial intelligence system slightly outperformed radiologists using PI-RADS at detecting clinically significant prostate cancer. A trained artificial intelligence (AI) system discriminated ...

PSMA-based PET imaging in newly diagnosed, high-risk localized prostate cancer, a National Cancer Institute (NCI) Cancer Moonshot trial. This is an ASCO Meeting Abstract from the 2025 ASCO ...